Stereotaxis, Inc. (STXS)

Market Cap	185.72M
Revenue (ttm)	27.51M
Net Income (ttm)	-26.65M
Shares Out	85.98M
EPS (ttm)	-0.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	239,756
Open	2.120
Previous Close	2.130
Day's Range	2.100 - 2.190
52-Week Range	1.540 - 2.716
Beta	1.44
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2025

About STXS

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminat...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Aug 12, 2004
• Employees: 139
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: STXS
• Website: https://www.stereotaxis.com

Financial Performance

In 2024, Stereotaxis's revenue was $26.92 million, an increase of 0.55% compared to the previous year's $26.77 million. Losses were -$25.35 million, 14.9% more than in 2023.